License U of T Technologies

Who is this for?

Industry and other parties interested in licensing or otherwise using University of Toronto (U of T) technologies or working with spinoff companies based on U of T intellectual property.

What do I need before I can begin?

No information is required to begin. If you have questions regarding licensing University of Toronto (U of T) technologies or working with our spinoff companies, please reach out to the Innovations & Partnerships Office: Director, Innovations at 416-946-5515.

Technology Licensing & Startup Opportunities

The University of Toronto (U of T) is a global leader in turning research into products, services, companies and jobs. The Innovations & Partnerships Office (IPO) is your one-stop-shop to license these technologies or work with spinoff companies based on U of T intellectual property (IP). IPO’s team of technology transfer professionals makes the process as quick and easy as possible.

Use our technology explorer to discover market-ready innovations and companies based on U of T IP or contact us to find custom solutions.
 

Technology Keywords
Recombinant Antibodies Network (RAN) Antibodies , Cancer , Advanced Health Technologies , Biotechnology , Pharmaceuticals , Therapeutics 
Rapid, remote vital sign monitoring and screening Advanced Health Technologies , Covid-19 , Remote monitoring , Patient Care , Biometrics , Biomedical engineering , Biomedical Imaging , Biosensor , Software , 3D imaging , Image and video processing , Screening 
Novel Counter-Measure Against Nerve Gas & Other Organophosphate/Carbamate Poisoning Advanced Health Technologies , Drug Discovery , Health & Related Life Sciences , molecular mechanisms , Pharmaceutical Research / Manufacturing , Pharmaceuticals , Small Molecules 
Targeting the Hippo Pathway for Cancer & Fibrosis Advanced Health Technologies , Biotechnology , Cancer , Cell Signaling , Drug Discovery , Health & Related Life Sciences , Inflammation , Pharmaceuticals , Small Molecules , Therapeutics 
Inhibition of PKN1 As Therapy For Chronic Lymphocytic Leukemia (CLL) Advanced Health Technologies , Biotechnology , Cancer , Drug Discovery , Health & Related Life Sciences , Leukemia , Pharmaceuticals , Small Molecules , Therapeutics 
SanoMetrics: AI-powered sleep disease classification and health metrics from wearables Advanced Health Technologies , Artificial Intelligence (AI) , Deep Learning , Data Analytics , Research Tools , Diagnostics , Software , Wearable Tech , Remote monitoring 
A Multi-Targeting CRISPR-Cas System for Systematic and Combinatorial Genetic Perturbation Advanced Health Technologies , Drug Discovery , Functional Genomics , Gene Editing , Gene Expression , Genetics , Health & Related Life Sciences , molecular mechanisms , Pharmaceutical Research / Manufacturing , Pharmaceuticals , Research Tools 
Autoscribe: AI-Powered Voice Assistant for Clinicians Advanced Health Technologies , Artificial Intelligence (AI) , Audio , Communications , Companies , Deep Learning , Health & Related Life Sciences , Human-Computer Interaction , Machine Learning , Natural Language Processing (NLP) , Patient Care , Point-of-Care , Software 
Cryosparc: Accelerated Protein Structure Determination from Cryo-EM 3D imaging , Advanced Health Technologies , Artificial Intelligence (AI) , Companies , Drug Discovery , Electron Microscopy , Machine Learning , Pharmaceutical Research / Manufacturing , Pharmaceuticals , Proteins , Research Tools , Software 
Glucose-Responsive Microgels and Microneedle Patch to Prevent Hypoglycemia in Diabetics Advanced Health Technologies , Biomaterials , Biotechnology , Medical Devices , metabolic syndromes , Nanomaterials and Nanoparticles , Sensors & Instrumentation , Therapeutics 

VPRI Role

  • Market U of T technologies to industry
  • Support the development of startup companies
  • Negotiate license agreements with interested companies
  • Assist in finding partners and funding to support proof-of-concept and commercialization
  • Support long-term relationships with strategic partners that help develop early-stage discoveries into market-ready technologies and products

VPRI Contact

Staff

Jennifer Fraser

Director, Innovations
Innovations & Partnerships Office (IPO)
(416) 946-5515
Radio Options- Did you find this useful?
Did you find this useful?
Let us know if you found this page useful. Did you find the information you were looking for?